10:25 AM EST - Knight Therapeutics Inc. : Reported financial results for its second quarter ended June 30, 2023. Revenues were $89.905 million, an increase of 19% over the same period in prior-year. Net income was $1.84 million, compared to $2,516 in the same period in the prior year.
Knight Therapeutics Inc.
shares T.GUD are trading up $0.05 at $4.88.
